SCHEMBL20156293

SCHEMBL20156293

CCOC(=O)/C(C(C)=N)=C(\C)NCCC1(C)OCCO1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20156326 0.75 ALDH1A1 (0.42) KMT2A
SCHEMBL20156005 0.70 ALDH1A1 (0.33)
SCHEMBL20156241 0.69 ALDH1A1 (0.38)
SCHEMBL16181353 0.66 CASP2 (0.46) KMT2A
SCHEMBL20156038 0.66 ALDH1A1 (0.36)
SCHEMBL11608944 0.66 FAAH (0.45) KMT2A
SCHEMBL135497 0.66 LMNA (0.44) KMT2A
SCHEMBL20156072 0.65
SCHEMBL20156305 0.65
SCHEMBL20156239 0.64 KMT2A (0.33) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538527-B1 AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2021-10-13 EP disclosed
WO-2018089358-A1 AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-17 WO disclosed